Results 131 to 140 of about 65,673 (219)

Successful Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection with Sulbactam-Durlobactam: A Two-Case Report. [PDF]

Infect Drug Resist
Liu F, Wang DW.
europepmc   +1 more source

Molecular determinants associated with resistance to imipenem and imipenem-relebactam in clinical Pseudomonas aeruginosa isolates. [PDF]

BMC Genomics
Lorusso AB, de Souza J, Bail L, Ito CAS, Carrara JA, Tuon FFB, Faoro H.   +6 more
europepmc   +1 more source

Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects. [PDF]

Antimicrob Agents Chemother
Rodvold K, Gotfried M, Kocharyan A, Mamikonyan G, Shi Q, Zhao H, Hu T, Xu A, Le M, Li J.   +9 more
europepmc   +1 more source

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies. [PDF]

Antimicrob Agents Chemother
Hernández-García M, Pérez-Viso B, Nieto-Torres M, García-Castillo M, Michelena M, Martínez-Martínez L, Baquero F, Ruiz-Garbajosa P, Cantón R.   +8 more
europepmc   +1 more source

Antibiotic exposure and recovery of persister states influence virulence phenotypes in Pseudomonas aeruginosa. [PDF]

Arch Microbiol
da Cruz Nizer WS, Igídio CED, Ribeiro EM, Andrade ACO, de Oliveira SN, Teixeira MM, de Souza DDG, Fagundes CT.   +7 more
europepmc   +1 more source

Characterization of <i>blaNDM-1</i> and <i>blaOXA-23</i>-Type Carbapenemases in <i>Acinetobacter baumannii</i> Isolated from Post-Surgical Patients. [PDF]

Antibiotics (Basel)
Gul S, Ali N, Qasim M, Alahmad M, Khan MS, Nourain ZE, Zaman S, Muhammad Y, Ullah W.   +8 more
europepmc   +1 more source

2''-O-galloylhyperin as a novel adjuvant to reduce imipenem resistance in multidrug-resistant Pseudomonas aeruginosa: transcriptome-based mechanism of iron homeostasis disruption. [PDF]

BMC Microbiol
Zheng L, Lu GJ, Wang ZX, Guo XJ, Wang Z, Shao ZY, Wang YT, Jiang HB, Chen ST, Wang FY, Li J, Lin YQ, Zheng SS, Lu GH, Qi JF, Zhu LW.   +15 more
europepmc   +1 more source

Selecting the Most Robust Imipenem Pharmacokinetic Model Requires Paired Forecasts and Explicit Metric Weighting [Letter]. [PDF]

Drug Des Devel Ther
Zhang X.
europepmc   +1 more source

Synergistic Effects of Amikacin With Imipenem and Ciprofloxacin Against Multidrug-Resistance Uropathogenic <i>Escherichia coli</i>. [PDF]

Can J Infect Dis Med Microbiol
Moharerpour SS, Ahmadi Parviji F, Javadi K, Halaji M.   +3 more
europepmc   +1 more source

Trends in the Frequency and Antimicrobial Resistance of Common Gram-Negative Bacilli Isolated From Urine Cultures. [PDF]

APMIS
Castellano-Sánchez L, Rosales-Castillo A, Requena-Fernández L, Ramos-Bermúdez M, Esteban-Martín V, Gutiérrez-Fernández J.   +5 more
europepmc   +1 more source